ATE492815T1 - Diagnostik-biomolekül(e) - Google Patents
Diagnostik-biomolekül(e)Info
- Publication number
- ATE492815T1 ATE492815T1 AT07794274T AT07794274T ATE492815T1 AT E492815 T1 ATE492815 T1 AT E492815T1 AT 07794274 T AT07794274 T AT 07794274T AT 07794274 T AT07794274 T AT 07794274T AT E492815 T1 ATE492815 T1 AT E492815T1
- Authority
- AT
- Austria
- Prior art keywords
- biomolecule
- diagnostic biomolecule
- diagnostic
- quantitating
- quantification
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57449—Specifically defined cancers of ovaries
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG200605961-2A SG140505A1 (en) | 2006-09-05 | 2006-09-05 | Diagnostic biomolecule(s) |
| PCT/SG2007/000264 WO2008030186A1 (en) | 2006-09-05 | 2007-08-20 | Diagnostic biomolecule(s) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE492815T1 true ATE492815T1 (de) | 2011-01-15 |
Family
ID=39157516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07794274T ATE492815T1 (de) | 2006-09-05 | 2007-08-20 | Diagnostik-biomolekül(e) |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8551712B2 (de) |
| EP (1) | EP2074427B1 (de) |
| CN (1) | CN101589308B (de) |
| AT (1) | ATE492815T1 (de) |
| AU (1) | AU2007293693C1 (de) |
| DE (1) | DE602007011476D1 (de) |
| ES (1) | ES2362121T3 (de) |
| MY (1) | MY145455A (de) |
| SG (1) | SG140505A1 (de) |
| WO (1) | WO2008030186A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201021509D0 (en) * | 2010-12-20 | 2011-02-02 | Reactivlab Ltd | Assay method |
| ES2625288T3 (es) | 2011-04-15 | 2017-07-19 | The Johns Hopkins University | Sistema de secuenciación segura |
| EP2728358B1 (de) * | 2011-06-29 | 2016-10-05 | Paichai University Industry-Academic Cooperation Foundation | Haptoglobin alpha-r als marker zur diagnose von lungenkrebs |
| ES2701742T3 (es) | 2012-10-29 | 2019-02-25 | Univ Johns Hopkins | Prueba de Papanicolaou para cánceres de ovario y de endometrio |
| EP3077826B1 (de) * | 2013-12-05 | 2020-05-13 | Universität Leipzig | Verfahren und mittel zur nichtinvasiven diagnose von typ-ii-diabetes mellitus |
| US11286531B2 (en) | 2015-08-11 | 2022-03-29 | The Johns Hopkins University | Assaying ovarian cyst fluid |
| WO2017204295A1 (ja) * | 2016-05-27 | 2017-11-30 | 和光純薬工業株式会社 | 消化器癌の判定方法 |
| TWI709188B (zh) | 2018-09-27 | 2020-11-01 | 財團法人工業技術研究院 | 基於機率融合的分類器、分類方法及分類系統 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9723773D0 (en) * | 1997-11-12 | 1998-01-07 | Univ Glasgow | Haptoglobin assay |
| US7112408B2 (en) * | 2001-06-08 | 2006-09-26 | The Brigham And Women's Hospital, Inc. | Detection of ovarian cancer based upon alpha-haptoglobin levels |
| CA2537955A1 (en) * | 2003-09-05 | 2005-03-17 | Royal Women's Hospital | Diagnostic marker for ovarian cancer |
| WO2007002535A2 (en) * | 2005-06-24 | 2007-01-04 | Ciphergen Biosystems, Inc. | Biomarkers for ovarian cancer |
-
2006
- 2006-09-05 SG SG200605961-2A patent/SG140505A1/en unknown
-
2007
- 2007-08-20 US US12/440,004 patent/US8551712B2/en active Active
- 2007-08-20 WO PCT/SG2007/000264 patent/WO2008030186A1/en active Application Filing
- 2007-08-20 EP EP07794274A patent/EP2074427B1/de active Active
- 2007-08-20 CN CN200780040599XA patent/CN101589308B/zh active Active
- 2007-08-20 ES ES07794274T patent/ES2362121T3/es active Active
- 2007-08-20 AT AT07794274T patent/ATE492815T1/de not_active IP Right Cessation
- 2007-08-20 AU AU2007293693A patent/AU2007293693C1/en active Active
- 2007-08-20 DE DE602007011476T patent/DE602007011476D1/de active Active
-
2009
- 2009-03-05 MY MYPI20090894A patent/MY145455A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101589308B (zh) | 2013-11-13 |
| EP2074427B1 (de) | 2010-12-22 |
| WO2008030186A1 (en) | 2008-03-13 |
| MY145455A (en) | 2012-02-15 |
| AU2007293693A1 (en) | 2008-03-13 |
| EP2074427A4 (de) | 2010-01-27 |
| US8551712B2 (en) | 2013-10-08 |
| SG140505A1 (en) | 2008-03-28 |
| WO2008030186A8 (en) | 2009-07-23 |
| DE602007011476D1 (de) | 2011-02-03 |
| AU2007293693C1 (en) | 2013-11-14 |
| EP2074427A1 (de) | 2009-07-01 |
| CN101589308A (zh) | 2009-11-25 |
| ES2362121T3 (es) | 2011-06-28 |
| AU2007293693B2 (en) | 2013-08-01 |
| US20100158916A1 (en) | 2010-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE492815T1 (de) | Diagnostik-biomolekül(e) | |
| NO20083820L (no) | Deteksjon av kreft ved forhoyede nivaer av BCL-2 | |
| DK1889059T3 (da) | Fremgangsmåde til forbedret immunoassay | |
| WO2008134526A3 (en) | Glycoprotein profiling of bladder cancer | |
| ATE536553T1 (de) | Verfahren zum nachweis grösserer ungünstiger kardiovaskulärer und zerebrovaskulärer ereignisse | |
| MY157955A (en) | Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody | |
| DE602007013524D1 (de) | Erkennung und vorhersage von frühgeburten | |
| ATE471512T1 (de) | Verwendung des proteins s100a 12 als marker für kolorektalkarzinom | |
| HK1149956A1 (en) | Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex | |
| GB2437545B (en) | Dextrin-containing reagents for detecting and quantifying proteins | |
| PL1977244T3 (pl) | Rozróżnianie bakteryjnego i wirusowego zapalenia opon mózgowych | |
| DE60325382D1 (de) | Verfahren zur diagnose von gebärmutterhalskrebs | |
| WO2006096697A3 (en) | Methods for determining the bivalency of protein and antibody therapeutics | |
| ATE468535T1 (de) | Verwendung von nnmt als marker für lungenkrebs | |
| WO2011109112A3 (en) | Method of detecting tau protein and tau fragments in serum | |
| CY1117709T1 (el) | Αναλυτικη μεθοδος για μορια fab και fab' | |
| DE602005014659D1 (de) | Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebs | |
| DE602004001994D1 (de) | Verwendung des proteins masp als marker für kolorektale karzinome | |
| PL1991875T3 (pl) | Test do wykrywania patologicznych prionów | |
| DE602005026587D1 (de) | Verwendung eines endoplasmin-fragments und von derivaten davon als biomarker für kolorektaladenom und/oder -karzinom; nachweisverfahren und testsystem | |
| ATE529745T1 (de) | Verfahren zur bewertung des hautempfindlichkeitsniveaus durch verwendung von mit plattenepithelkarzinom zusammenhängendem antigen als indikation | |
| GB0802456D0 (en) | Diagnostic method | |
| DE602007010157D1 (de) | Verfahren zur erkennung von listerien | |
| GB0501564D0 (en) | Test for prion disease | |
| ATE532074T1 (de) | Auf multi-immunoaffinität basierende indentifizierung von antigenen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |